Melanoma Immunotherapy with Dr. Jedd Wolchok

Dr. Jedd Wolchok leads a discussion on immunotherapy for melanoma, including new cancer research and treatments. #CRIsummit #immunotherapy #melnm
www.cancerresearch.org/virtua...
Immunotherapy has forever changed the way melanoma is treated. Checkpoint inhibitors, beginning with the landmark 2011 FDA approval of ipilimumab (Yervoy®), are responsible for the increasing survival rate for patients with metastatic melanoma. Nowcientists and clinicians are working to bring the benefits of immunotherapy to more patients with melanoma. www.cancerresearch.org/immuno...
In this video, Dr. Jedd D. Wolchok (Memorial Sloan Kettering Cancer Center)  addresses:
- Immune checkpoint inhibitors
- Tumor-infiltrating lymphocytes
- Cancer immunotherapy side effects
- Standard of care for melanoma
- Cancer immunotherapy clinical trials
- Tumor mutations, such as BRAF and MEK
- Oncolytic virus therapy, including T-VEC
- Combination therapies, such as surgery + immunotherapy, combination immunotherapes, intratumoral injections
- How to tell when immunotherapy is working
- Treatment regimen decisions, such as length of treatment
- Stages of disease and treatment decisions for melanoma
- Overall health of melanoma patient, such as diet and exercise
Dr. Wolchok is a medical oncologist and immunotherapy researcher at Memorial Sloan Kettering Cancer Center (MSK), where he is the chief of Melanoma & Immunotherapeutics Service, the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation, the director of the Parker Institute for Cancer Immunotherapy at MSK, and the associate director of the Ludwig Center for Cancer Immunotherapy. He is also an associate director of the Cancer Research Institute Scientific Advisory Council and chair of the CRI Clinical Trials Network. Dr. Wolchok has been at the forefront of cancer immunotherapy and is renowned for leading the clinical trials that led to the first FDA-approved checkpoint inhibitor immunotherapy, the anti-CTLA-4 antibody ipilimumab (Yervoy®). He directs a translational research laboratory focused on next-generation immunotherapies and combination therapies. www.cancerresearch.org/about-...
The 2020 CRI Virtual Immunotherapy Patient Summit is part of the Cancer Research Institute's Answer to Cancer Patient Education Program. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

[@PaulBeiser]

Wow! This is great. Just diagnosed, this gives me hope. Thank you!

[@IVORY123100]

I was diagnosed with stage 4 melanoma . 70 Dr visits in the last year . It went to my brain and I had 3 tumors . With Truebeam radiation and Opdivo . It was either a miracle or how much better they treat the worst of the worst today . I was shocked when told . Cancer has vanished !!! Also told had it been diagnosed like it was 5 years ago .. I would have been given 3 months to live last year ..

[@PaulBeiser]

@@IVORY123100 that’s astounding and great!

[@germanshepherdmom1143]

I’m here because I’ve been watching vlogs from a person who lost her battle to this disease. In my humble opinion, she didn’t have good enough doctors.

[@waeljohn168]

Thank you for such an informative session! As a Melanoma survivor it makes me happy to see the advancements in immunotherapy. Nivolomab and my amazing doctor Hwu saved my life!!

[@hardrock6034]

Great presentation. Thank you!

[@germanshepherdmom1143]

If melanoma spreads to the brain, does it cause similar tumors as say glioblstoma ?

[@CancerResearchInstitute]

Hi there- it would still be melanoma if the tumor spreads. You can learn more about melanoma and immunotherapy by visiting our website: www.cancerresearch.org/Immunotherapy/Cancer-Types/Melanoma

[@jackieearl1412]

Great! Now I hope doctors can tell me why I am now in my 31st year of remission after being diagnosed at 4.5, or fatal? My lymph nodes came back clean after most of right thigh & right nodes removed in 9 hour surgery on 1/2/89. How am I alive after ignoring new ugly mole for at least 2 years?

[@germanshepherdmom1143]

That is great. Unfortunately, many with stage 4 melanoma don’t make it.

[@nancyparr91]

Thank you for such an informative session! As a Melanoma survivor it makes me happy to see the advancements in immunotherapy. Nivolomab and my amazing doctor Hwu saved my life!!

[@CancerResearchInstitute]

Thank you for sharing and watching with us, Nancy!